Published in PLoS One on August 11, 2010
GeneXpert--a game-changer for tuberculosis control? PLoS Med (2011) 2.38
Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil. J Bras Pneumol (2014) 0.88
Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatment. PLoS One (2011) 0.88
A predictive scoring instrument for tuberculosis lost to follow-up outcome. Respir Res (2012) 0.77
Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe. Int J Tuberc Lung Dis (2016) 0.77
Rationing tests for drug-resistant tuberculosis - who are we prepared to miss? BMC Med (2016) 0.75
Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil. BMC Infect Dis (2017) 0.75
Serious fungal infections in Peru. Eur J Clin Microbiol Infect Dis (2017) 0.75
Clinical prediction rules. Applications and methodological standards. N Engl J Med (1985) 7.72
Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA (1997) 7.71
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet (2009) 7.22
Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA (2000) 5.94
Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax (2005) 3.81
Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med (2006) 3.70
Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis (2001) 3.51
Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis (1999) 3.08
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax (2005) 2.09
Advanced statistics: bootstrapping confidence intervals for statistics with "difficult" distributions. Acad Emerg Med (2005) 1.96
Multidrug resistance among persons with tuberculosis in California, 1994-2003. JAMA (2005) 1.88
Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda. BMC Infect Dis (2010) 1.66
Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect Dis (2010) 1.52
TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis (2008) 1.44
A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist (2005) 1.33
An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia. PLoS One (2009) 1.27
Drug-resistant tuberculosis in a southern California hospital. Trends from 1969 to 1984. Am Rev Respir Dis (1987) 1.25
Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study. PLoS One (2008) 1.19
Predictors of extensively drug-resistant pulmonary tuberculosis. Ann Intern Med (2009) 1.18
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries. Clin Infect Dis (2008) 1.17
Drug-susceptibility testing in TB: current status and future prospects. Expert Rev Respir Med (2009) 1.10
A clinical prediction rule for pulmonary tuberculosis in emergency departments. Int J Tuberc Lung Dis (2008) 0.93
Validity of clinical prediction rules for isolating inpatients with suspected tuberculosis. A systematic review. J Gen Intern Med (2005) 0.91
Development of a clinical scoring system for the diagnosis of smear-negative pulmonary tuberculosis. Braz J Infect Dis (2008) 0.91
Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis. Arch Intern Med (1995) 0.91
Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol (2008) 0.86
Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic. Int J Tuberc Lung Dis (2010) 0.85
Thai drug-resistant tuberculosis predictive scores. Singapore Med J (2009) 0.82
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis (2003) 15.02
Reassessment of clinical practice guidelines: go gently into that good night. JAMA (2009) 5.91
Maintenance of certification: beauty is in the eyes of the beholder. Ann Intern Med (2014) 5.21
Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med (2014) 4.95
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. J Acquir Immune Defic Syndr (2007) 4.67
Retainer medicine: an ethically legitimate form of practice that can improve primary care. Ann Intern Med (2011) 4.61
The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med (2015) 4.49
A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol Microbiol (2002) 4.26
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med (2011) 4.21
Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis (2007) 3.80
Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol (2007) 3.22
Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol (2007) 2.85
Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J (2005) 2.77
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis (2010) 2.60
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr (2009) 2.15
To be a great physician, you must understand the whole story. MedGenMed (2007) 2.14
Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg (2008) 2.09
Characterization of long-term outcomes after Toupet fundoplication: symptoms, medication use, and health status. J Clin Gastroenterol (2002) 2.08
Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother (2002) 2.00
The role of imaging in pediatric bladder augmentation. Pediatr Radiol (2015) 1.99
The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis (2013) 1.96
Cutaneous tuberculosis. Clin Dermatol (2007) 1.92
Atypical presentations among Medicare beneficiaries with unstable angina pectoris. Am J Cardiol (2002) 1.92
Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med (2006) 1.92
Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2008) 1.87
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection. J Acquir Immune Defic Syndr (2009) 1.83
Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother (2007) 1.81
Nurse staffing and mortality for Medicare patients with acute myocardial infarction. Med Care (2004) 1.77
Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis (2003) 1.70
Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis (2008) 1.70
High prevalence of HIV and syphilis in a remote native community of the Peruvian Amazon. Am J Trop Med Hyg (2007) 1.70
Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses (2006) 1.67
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. Am J Respir Crit Care Med (2011) 1.66
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev (2016) 1.66
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med (2002) 1.61
Educational programs to enhance medical expertise in tropical diseases: the Gorgas Course experience 1996-2001. Am J Trop Med Hyg (2002) 1.60
Update on strongyloidiasis in the immunocompromised host. Curr Infect Dis Rep (2011) 1.59
A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru. Trop Med Int Health (2006) 1.55
Environmental temperature, cholera, and acute diarrhoea in adults in Lima, Peru. J Health Popul Nutr (2004) 1.54
Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PLoS One (2011) 1.53
Current status of carbapenemases in Latin America. Expert Rev Anti Infect Ther (2013) 1.52
Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development. Front Cell Infect Microbiol (2012) 1.52
Genera in Bionectriaceae, Hypocreaceae, and Nectriaceae (Hypocreales) proposed for acceptance or rejection. IMA Fungus (2013) 1.49
Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Negl Trop Dis (2010) 1.46
Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis (2010) 1.45
Zoonoses and marginalised infectious diseases of poverty: where do we stand? Parasit Vectors (2011) 1.44
Use of ivermectin to treat an institutional outbreak of scabies in a low-resource setting. Infect Control Hosp Epidemiol (2007) 1.44
Scholarship opportunities for trainees and clinician educators: learning outcomes from a case report writing workshop. J Gen Intern Med (2008) 1.40
The activities and responsibilities of the vice chair for education in U.S. and Canadian departments of medicine. Acad Med (2012) 1.39
Histopathological features of tungiasis in Peru. Am J Trop Med Hyg (2013) 1.39
Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother (2004) 1.39
Genome-wide operon prediction in Staphylococcus aureus. Nucleic Acids Res (2004) 1.38
Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. PLoS One (2010) 1.37
Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg (2008) 1.37
Relationship between intensity of soil-transmitted helminth infections and anemia during pregnancy. Am J Trop Med Hyg (2005) 1.36
Management of extensively drug-resistant tuberculosis in Peru: cure is possible. PLoS One (2008) 1.34
Strongyloides stercoralis: a plea for action. PLoS Negl Trop Dis (2013) 1.33
Diversity of bat-associated Leptospira in the Peruvian Amazon inferred by bayesian phylogenetic analysis of 16S ribosomal DNA sequences. Am J Trop Med Hyg (2005) 1.33
Burden of comorbid medical conditions and quality of diabetes care. Diabetes Care (2007) 1.30
A pilot study using nominal group technique to assess residents' perceptions of successful attending rounds. J Gen Intern Med (2008) 1.29
Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis (2006) 1.28
Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans. J Proteome Res (2011) 1.24
Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis (2009) 1.23
Lobomycosis successfully treated with posaconazole. Am J Trop Med Hyg (2013) 1.23
When should patients seek care for sore throat? Ann Intern Med (2013) 1.22
Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg (2007) 1.22
Human febrile illness caused by encephalomyocarditis virus infection, Peru. Emerg Infect Dis (2009) 1.18
Idiopathic granulomatous mastitis: case reports and review of literature. J Gen Intern Med (2009) 1.18
Mechanical stretch is a highly selective regulator of gene expression in human bladder smooth muscle cells. Physiol Genomics (2004) 1.17
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries. Clin Infect Dis (2008) 1.17
The value of pituitary magnetic resonance imaging in men with hypogonadism. J Urol (2003) 1.14
Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement. Clin Infect Dis (2010) 1.13
Correlation of serotype-specific dengue virus infection with clinical manifestations. PLoS Negl Trop Dis (2012) 1.13
Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa. Trop Med Int Health (2012) 1.12
Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Int J Antimicrob Agents (2009) 1.12
Knowledge and attitudes of tuberculosis management in San Juan de Lurigancho district of Lima, Peru. J Infect Dev Ctries (2009) 1.10
Attending physicians on ward rounds. JAMA (2013) 1.09
Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens. PLoS Negl Trop Dis (2010) 1.08
A model of tuberculosis screening for pregnant women in resource-limited settings using Xpert MTB/RIF. J Pregnancy (2011) 1.08
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis. PLoS One (2013) 1.07
Sore Throat: Avoid Overcomplicating the Uncomplicated. Ann Intern Med (2015) 1.07
Identifying key components for an effective case report poster: an observational study. J Gen Intern Med (2008) 1.07
Erstwhile triple threat. J Gen Intern Med (2002) 1.07
Tuberculosis and HIV control in sub-Saharan African prisons: "thinking outside the prison cell". J Infect Dis (2012) 1.06
Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis (2005) 1.06
A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru. PLoS One (2012) 1.05
Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity. Chest (2003) 1.04